CINECA IRIS Institutional Research Information System

ANFOSSI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.818
AS - Asia 2.705
EU - Europa 2.490
SA - Sud America 502
AF - Africa 47
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.572
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.728
SG - Singapore 1.170
CN - Cina 877
UA - Ucraina 418
BR - Brasile 402
DE - Germania 374
IE - Irlanda 357
FI - Finlandia 287
IT - Italia 264
KR - Corea 250
FR - Francia 218
VN - Vietnam 212
SE - Svezia 182
GB - Regno Unito 148
PL - Polonia 116
AT - Austria 69
CA - Canada 64
HK - Hong Kong 53
AR - Argentina 44
IN - India 28
BD - Bangladesh 17
EC - Ecuador 17
IQ - Iraq 15
ID - Indonesia 14
RU - Federazione Russa 14
MX - Messico 13
CO - Colombia 12
ZA - Sudafrica 12
BE - Belgio 11
IR - Iran 11
JP - Giappone 11
SN - Senegal 10
GR - Grecia 9
PK - Pakistan 9
VE - Venezuela 9
NL - Olanda 8
PY - Paraguay 8
MA - Marocco 7
AE - Emirati Arabi Uniti 6
UZ - Uzbekistan 6
AU - Australia 5
UY - Uruguay 5
EG - Egitto 4
ES - Italia 4
JO - Giordania 4
TN - Tunisia 4
HN - Honduras 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
NP - Nepal 3
PA - Panama 3
CL - Cile 2
DZ - Algeria 2
GI - Gibilterra 2
IL - Israele 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
TR - Turchia 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TO - Tonga 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.572
Salva come PNG Salva come JPEG
Città #
Beijing 652
Singapore 615
Santa Clara 570
Dublin 355
Jacksonville 260
Chandler 255
Houston 165
Buffalo 154
Los Angeles 143
Princeton 138
Medford 121
Ashburn 112
Warsaw 111
Columbus 100
Ann Arbor 98
Villeurbanne 96
San Jose 95
Dearborn 85
Boston 78
Dallas 75
Ho Chi Minh City 71
Milan 71
Vienna 66
Fremont 60
Torino 53
Wilmington 51
Hong Kong 49
Nyköping 47
The Dalles 47
Verona 47
Munich 42
Hanoi 39
Hefei 38
Lachine 34
São Paulo 33
Philadelphia 27
New York 26
Lauterbourg 25
Dong Ket 23
Helsinki 22
Toronto 22
Turku 22
Fairfield 21
Boardman 20
Norwalk 20
Seoul 20
Falls Church 18
Guangzhou 17
Belo Horizonte 12
Falkenstein 12
Brussels 11
Kunming 11
Detroit 10
Tokyo 10
Athens 9
Rio de Janeiro 9
Savona 9
Curitiba 7
Da Nang 7
Guayaquil 7
Haiphong 7
Nanjing 7
Pune 7
Woodbridge 7
Ardabil 6
Baghdad 6
Biên Hòa 6
Brooklyn 6
Jinan 6
Monmouth Junction 6
Pasadena 6
San Francisco 6
Anguillara 5
Bengaluru 5
Brasília 5
Caxias do Sul 5
Chicago 5
Denver 5
Hebei 5
Nanchang 5
Phoenix 5
Phoenixville 5
Porto Alegre 5
Quận Bình Thạnh 5
Rome 5
Shenyang 5
Tashkent 5
Thái Bình 5
Zhengzhou 5
Amman 4
Atlanta 4
Campinas 4
Fortaleza 4
Frankfurt am Main 4
Guarulhos 4
Istrana 4
Itajaí 4
Johannesburg 4
Messina 4
Montevideo 4
Totale 5.628
Salva come PNG Salva come JPEG
Nome #
High glucose reduces the anti-aggregating effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 173
The Cardiovascular Effects of Metformin: Further Reasons to Consider an Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus 151
Le dislipidemie Aspetti biochimici e clinici 144
Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin 137
C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells 127
Effects of high glucose on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells from obese and lean zucker rats. 127
Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation. 126
Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein 126
Contribution of insulin resistance to vascular dysfunction 125
Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. 121
Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virus 116
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin 114
Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase. 112
Calcium-channel blocking agents verapamil and diltiazem are inhibitors of vasopressin-induced human platelet activation. 112
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets. 112
Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood 111
Relevance of the vascular effects of insulin in the rationale of its therapeutical use 111
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. 111
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance 110
Effect of dopamine on adenosine 3',5'-cyclic monophosphate levels in human platelets. 108
Comparison between the effects of the rapid recombinant insulin analog LYSPRO (Lys B28, Pro B29) and those of human regular insulin on platelet cyclic nucleotides and aggregation 107
Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress. 106
Arginine vasopressin release from human platelets after irreversible aggregation. 105
Clinically autonomous hepatic tuberculosis] 104
Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. 101
Immunomorphological aspects of the kidney in liver cirrhosis and obstructive jaundice 100
A double blind randomized placebo-controlled study demonstrates the protective efficacy of rosaprostol on aspirin-induced gastrointestinal bleeding in man. 98
Role of NMDA receptor in homocysteine-induced activation of Mitogen-Activated Protein Kinase and Phosphatidyl Inositol 3-Kinase pathways in cultured human vascular smooth muscle cells 98
Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells 96
A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents 96
Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets. 95
Alpha-adrenergic blockade with phentolamine increases the response of the renin-angiotensin-aldosterone system to insulin-induced hypoglycaemia in man. 94
Changes of renal lactate dehydrogenase isoenzymes (LDH) in the course of acute experimental tubular necrosis 94
Cholemic tubulonephrosis 94
High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism 93
Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway. 92
Desensitization of the platelet aggregation response to adrenaline during insulin-induced hypoglycaemia in man. 91
Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity. 91
A Platelet Defect Characterised by Absent Adrenaline-induced Aggregation and Lack of Secondary Aggregation in Response to ADP and Platelet-activating Factor. 90
Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study. 90
Consensus on: Screening and therapy of coronary heart disease in diabetic patients. 90
Urinary enzyme release following aminoglycoside administration in single low dose. 89
Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions. 89
Bile salts and spontaneous release of PGI2, TxA2 and fVIII from cultured human endothelial cells 89
Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling 87
White blood cell count is positively correlated with albumin excretion rate in subjects with type 2 diabetes 86
c-myc expression in cells infected with hepatitis delta virus. 85
Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome 85
An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. 84
Cryptococcosis in a female patient with angioimmunoblastic lymphadenopathy and dysproteinemia 84
Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients. 83
Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress 83
Pathogenetic aspects of cholemic nephropathy 80
Urinary enzyme excretion in acute and subacute experimental lithium administration 78
Na+/H+ antiporter activity in peripheral blood lymphocytes of obese and type 2 diabetic patients is increased only in the presence of arterial hypertension. 78
Urinary enzyme excretion and renal lactate dehydrogenase isoenzyme pattern in acute HgCl2 nephropathy of rat. 77
Sodium taurocholate affects prostacyclin constitutive production by cultured human vascular endothelial cells. 77
Use of urinary enzymes to evaluate renal damage. Physiopathological considerations and clinical applications 76
G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. 76
Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits 76
Type B viral hepatitis. Recent findings 75
Interplay between milrinone and adenosine in the inhibition of human platelet response. 75
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways 74
Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. 73
Proteina C-reattiva: dosare o non dosare nel paziente diabetico 72
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. 72
Platelet dysfunction in central obesity 72
Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content. 71
Normal human T limphocytes G1/S transition requires the nuclear protein encoded by c-MYB protooncogene 70
Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring. 70
Effects of anti-adrenergic drugs on thrombin-induced platelet aggregation and thromboxane B2 production 70
Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. 70
Na+/H+ antiporter properties in peripheral blood lymphocytes from normotensive obese and type 2 diabetic patients do not differ significantly from controls. 69
Nonenzymatic glycation of fibronectin impairs adhesive and proliferative properties of human vascular smooth muscle cells. 69
The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents 68
Insulin, at physiological concentrations, enhances the polymorphonuclear leukocyte chemotactic properties. 67
Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets. 67
Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study 67
Studies on the effect of dopamine on the human platelet response. 67
Mechanisms involved in platelet hyperactivation and platelet-endothelium interrelationships in diabetes mellitus. 67
Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function. 66
Insulin stimulates the polymorphonuclear leukocyte chemokinesis. 66
Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects. 66
Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate 66
Sodium azide in commercially available C-reactive protein preparations does not influence matrix metalloproteinase-2 synthesis and release in cultured human aortic vascular smooth muscle cells 66
Renal lactate dehydrogenase (LDH) isoenzyme pattern in short-term experimental obstructive nephropathy. 64
Effect of labetalol on human platelet function. 64
Studies on inhibition of human platelet response by diltiazem. 64
Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect. 63
Influence of age on polymorphonuclear leukocytes in vitro: phagocytic activity in healthy human subjects 63
Insulin exerts opposite effects on platelet function at physiological and supraphysiological concentrations. 63
Intrahepatic exIntrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon. 63
The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide. 63
Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3':5'-cyclic monophosphate and adenosine 3':5'-cyclic monophosphate concentrations. 63
Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production. 63
Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. 62
Role of catecholamines in platelet function: pathophysiological and clinical significance. 61
Glyceryl trinitrate enhances the adenosine-induced inhibition of platelet responses: a mechanism potentially involved in the in vivo anti-aggregating effects of organic nitrates. 61
Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells 60
L-arginine modulates aggregation and intracellular cyclic 3',5'-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative agent. 60
Totale 8.733
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.345
article - articoli 0
book - libri 0
conference - conferenze 457
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.802
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021345 0 0 0 0 0 0 69 7 125 80 19 45
2021/2022657 26 19 10 12 18 7 23 32 20 53 167 270
2022/2023982 144 37 22 42 122 327 121 46 80 15 23 3
2023/2024339 41 73 16 22 20 33 0 5 2 6 15 106
2024/20252.068 2 246 45 117 739 77 7 68 187 91 93 396
2025/20261.998 335 132 396 382 414 125 214 0 0 0 0 0
Totale 9.867